Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...